Percutaneous closure of atrial septal defects: immediate and mid-term results
- PMID: 20378511
Percutaneous closure of atrial septal defects: immediate and mid-term results
Abstract
Introduction: The incidence of percutaneous closure of secundum atrial septal defects (ASD) and patent foramen ovale (PFO), which has become an established therapy, is constantly increasing. In this study, which is the first in the Greek literature, we present the immediate and mid-term results from this intervention in our center.
Methods: From April 2004 to April 2008, 103 patients underwent percutaneous closure of an ASD or PFO using Amplatzer closure devices. Thirty were male, the mean age was 37 +/- 15.5 years, and the mean follow-up period 21.7 +/- 14.8 months. The procedure was successful in 102 of the above patients; 69 (mean age 36.3 years +/- 17.1, 81% female) underwent secundum ASD closure, while 33 patients (mean age 39.1 +/- 10.5 years, 16 female and 17 male) underwent percutaneous closure of a PFO due to cryptogenic stroke.
Results: There were no major complications during the procedure (death, device embolization or need for immediate cardiac surgery). There were minor complications in 8 (7.7%) patients (bleeding at the puncture site, transient ST elevation in the inferior leads, multiple atrial and ventricular ectopics). The transient ST elevation in the inferior leads appeared in 5 patients (5%) and was probably due to air embolization. This transient complication completely resolved within 3 minutes. During the follow-up period, no patient had a major complication (cardiac rupture, device embolization, thrombus formation, thromboembolism or infective endocarditis). Most importantly, in the patients who underwent PFO closure there were no recurrences of cryptogenic stroke during the follow-up period (24.3 +/- 14.5 months).
Conclusions: This study shows that using Amplatzer closure devices for atrial septal communications is both safe and effective, with sustained results over a maximum follow-up period of four years. Appropriate patient selection, as well as accurate device sizing fitting the dimensions of the defect, are important factors for the success and the safety of the method.
Similar articles
-
Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results.Congenit Heart Dis. 2013 Sep-Oct;8(5):418-27. doi: 10.1111/chd.12057. Epub 2013 Apr 22. Congenit Heart Dis. 2013. PMID: 23601507
-
Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.Rev Recent Clin Trials. 2017;12(2):129-138. doi: 10.2174/1574887112666170328124939. Rev Recent Clin Trials. 2017. PMID: 28356032 Review.
-
Percutaneous closure of inter-atrial communications (atrial septal defect and patent foramen ovale): single-centre experience and mid-term follow-up.Acta Cardiol. 2015 Apr;70(2):133-40. doi: 10.1080/ac.70.2.3073503. Acta Cardiol. 2015. PMID: 26148372
-
Simplified percutaneous closure of patent foramen ovale and atrial septal defect with use of plain fluoroscopy: Single operator experience in 110 consecutive patients.Indian Heart J. 2018 Jan-Feb;70(1):24-31. doi: 10.1016/j.ihj.2017.07.020. Epub 2017 Aug 8. Indian Heart J. 2018. PMID: 29455783 Free PMC article.
-
Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies.Catheter Cardiovasc Interv. 2013 Dec 1;82(7):1123-38. doi: 10.1002/ccd.24875. Epub 2013 Aug 31. Catheter Cardiovasc Interv. 2013. PMID: 23412921 Review.
Cited by
-
Novel technique to reduce prolapsed device in atrial septal defect closure.Front Cardiovasc Med. 2023 May 16;10:1164061. doi: 10.3389/fcvm.2023.1164061. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37260942 Free PMC article.
-
Transcatheter Atrial Septal Defect Closure under Transthorasic Echocardiography in Children.Iran J Pediatr. 2011 Dec;21(4):473-8. Iran J Pediatr. 2011. PMID: 23056834 Free PMC article.
-
Perforation of the atrial wall and aortic sinus after closure of an atrial septal defect with an Atriasept occluder: a case report.J Cardiothorac Surg. 2021 Mar 25;16(1):53. doi: 10.1186/s13019-021-01441-x. J Cardiothorac Surg. 2021. PMID: 33766059 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous